214 related articles for article (PubMed ID: 27862596)
61. Temporal trends in outcome and patient characteristics in dilated cardiomyopathy, data from the Swedish Heart Failure Registry 2003-2015.
Sjöland H; Silverdal J; Bollano E; Pivodic A; Dahlström U; Fu M
BMC Cardiovasc Disord; 2021 Jun; 21(1):307. PubMed ID: 34144681
[TBL] [Abstract][Full Text] [Related]
62. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
[TBL] [Abstract][Full Text] [Related]
63. Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience.
Kutyifa V; Geller L; Bogyi P; Zima E; Aktas MK; Ozcan EE; Becker D; Nagy VK; Kosztin A; Szilagyi S; Merkely B
Eur J Heart Fail; 2014 Dec; 16(12):1323-30. PubMed ID: 25379962
[TBL] [Abstract][Full Text] [Related]
64. An 8-year single-centre experience of cardiac resynchronisation therapy: procedural success, early and late complications, and left ventricular lead performance.
Ahsan SY; Saberwal B; Lambiase PD; Chaubey S; Segal OR; Gopalamurugan AB; McCready J; Rogers DP; Lowe MD; Chow AW
Europace; 2013 May; 15(5):711-7. PubMed ID: 23315159
[TBL] [Abstract][Full Text] [Related]
65. A Contemporary Analysis of Heart Transplantation and Bridge-to-Transplant Mechanical Circulatory Support Outcomes in Cardiac Sarcoidosis.
Crawford TC; Okada DR; Magruder JT; Fraser C; Patel N; Houston BA; Whitman GJ; Mandal K; Zehr KJ; Higgins RS; Chen ES; Tandri H; Kasper EK; Tedford RJ; Russell SD; Gilotra NA
J Card Fail; 2018 Jun; 24(6):384-391. PubMed ID: 29482029
[TBL] [Abstract][Full Text] [Related]
66. Arrhythmogenic right ventricular dysplasia/cardiomyopathy and cardiac sarcoidosis: distinguishing features when the diagnosis is unclear.
Philips B; Madhavan S; James CA; te Riele AS; Murray B; Tichnell C; Bhonsale A; Nazarian S; Judge DP; Calkins H; Tandri H; Cheng A
Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):230-6. PubMed ID: 24585727
[TBL] [Abstract][Full Text] [Related]
67. Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial.
Tompkins CM; Kutyifa V; Arshad A; McNitt S; Polonsky B; Wang PJ; Moss AJ; Zareba W
J Cardiovasc Electrophysiol; 2015 Aug; 26(8):862-871. PubMed ID: 25929699
[TBL] [Abstract][Full Text] [Related]
68. The prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy.
Gulati A; Ismail TF; Jabbour A; Alpendurada F; Guha K; Ismail NA; Raza S; Khwaja J; Brown TD; Morarji K; Liodakis E; Roughton M; Wage R; Pakrashi TC; Sharma R; Carpenter JP; Cook SA; Cowie MR; Assomull RG; Pennell DJ; Prasad SK
Circulation; 2013 Oct; 128(15):1623-33. PubMed ID: 23965488
[TBL] [Abstract][Full Text] [Related]
69. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis.
Tahara N; Tahara A; Nitta Y; Kodama N; Mizoguchi M; Kaida H; Baba K; Ishibashi M; Hayabuchi N; Narula J; Imaizumi T
JACC Cardiovasc Imaging; 2010 Dec; 3(12):1219-28. PubMed ID: 21163450
[TBL] [Abstract][Full Text] [Related]
70. Prognostic significance of left ventricular dyssynchrony by phase analysis of gated SPECT in medically treated patients with dilated cardiomyopathy.
Wang L; Yang MF; Cai M; Zhao SH; He ZX; Wang YT
Clin Nucl Med; 2013 Jul; 38(7):510-5. PubMed ID: 23698460
[TBL] [Abstract][Full Text] [Related]
71. Cardiovascular drug utilization post-implant is related to clinical outcome in heart failure patients receiving cardiac resynchronization therapy.
Bakos Z; Reitan C; Werther-Evaldsson A; Roijer A; Platonov P; Borgquist R
Cardiol J; 2017; 24(4):374-384. PubMed ID: 28198522
[TBL] [Abstract][Full Text] [Related]
72. Effects of ventricular conduction block patterns on mortality in hospitalized patients with dilated cardiomyopathy: a single-center cohort study.
Li X; Luo R; Fang W; Xu X; Niu G; Xu Y; Fu M; Hua W; Wu X
BMC Cardiovasc Disord; 2016 Jun; 16():136. PubMed ID: 27296108
[TBL] [Abstract][Full Text] [Related]
73. Comparison of heart transplantation patients with ischemic and idiopathic dilated cardiomyopathy.
Gungor H; Oguz E; Ayik MF; Ertugay S; Engin C; Yagdi T; Nalbantgil S; Zoghi M; Ozbaran M
Transplant Proc; 2011 Dec; 43(10):3847-50. PubMed ID: 22172858
[TBL] [Abstract][Full Text] [Related]
74. Probability and magnitude of response to cardiac resynchronization therapy according to QRS duration and gender in nonischemic cardiomyopathy and LBBB.
Varma N; Manne M; Nguyen D; He J; Niebauer M; Tchou P
Heart Rhythm; 2014 Jul; 11(7):1139-47. PubMed ID: 24704570
[TBL] [Abstract][Full Text] [Related]
75. Effect of Corticosteroid Therapy on Long-Term Clinical Outcome and Left Ventricular Function in Patients With Cardiac Sarcoidosis.
Nagai T; Nagano N; Sugano Y; Asaumi Y; Aiba T; Kanzaki H; Kusano K; Noguchi T; Yasuda S; Ogawa H; Anzai T
Circ J; 2015; 79(7):1593-600. PubMed ID: 25877828
[TBL] [Abstract][Full Text] [Related]
76. Cardiac resynchronization therapy as a therapeutic option in patients with moderate-severe functional mitral regurgitation and high operative risk.
van Bommel RJ; Marsan NA; Delgado V; Borleffs CJ; van Rijnsoever EP; Schalij MJ; Bax JJ
Circulation; 2011 Aug; 124(8):912-9. PubMed ID: 21810666
[TBL] [Abstract][Full Text] [Related]
77. [Electrocardiographic predictors of response to cardiac resynchronization therapy of heart failure in patients with dilated cardiomyopathy].
Vaĭkhanskaia TG; Kurushko TV; Sidorenko IV; Koptiukh TM; Gul' LM; Mel'nikova OP; Golenishcha VF; Kovalenko ON
Kardiologiia; 2013; 53(3):48-54. PubMed ID: 23548427
[TBL] [Abstract][Full Text] [Related]
78. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure.
Sundell J; Engblom E; Koistinen J; Ylitalo A; Naum A; Stolen KQ; Kalliokoski R; Nekolla SG; Airaksinen KE; Bax JJ; Knuuti J
J Am Coll Cardiol; 2004 Mar; 43(6):1027-33. PubMed ID: 15028362
[TBL] [Abstract][Full Text] [Related]
79. Prognosis after pacemaker implantation in cardiac sarcoidosis in Japan. Clinical evaluation of corticosteroid therapy.
Takada K; Ina Y; Yamamoto M; Satoh T; Morishita M
Sarcoidosis; 1994 Sep; 11(2):113-7. PubMed ID: 7809494
[TBL] [Abstract][Full Text] [Related]
80. Quantification of ventricular resynchronization reserve by radionuclide phase analysis in heart failure patients: a prospective long-term study.
Dauphin R; Nonin E; Bontemps L; Vincent M; Pinel A; Bonijoly S; Barborier D; Ribier A; Fernandes CM; Bert-Marcaz P; Itti R; Chevalier P
Circ Cardiovasc Imaging; 2011 Mar; 4(2):114-21. PubMed ID: 21239562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
